跳至主要内容
临床试验/NCT01376206
NCT01376206已完成不适用

Drug Use Investigation for ALLERMIST

GlaxoSmithKline0 个研究点目标入组 2,000 人开始时间: 2009年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
2,000
主要终点
The number of adverse events in Japanese subjects with allergic rhinitis treated with fluticasone nasal spray

研究概览

简要总结

To investigate possible problems or questions in safety and efficacy of ALLERMIST Nasal Spray in Japanese subjects with allergic rhinitis under the practical use conditions

研究设计

研究类型
Observational
观察模型
Other
时间视角
Other

入排标准

性别
All
接受健康志愿者

入选标准

  • Diagnosis of allergic rhinitis
  • Use ALLERMIST for the first time
  • Expected to use ALLERMIST for long-term (1 year)

排除标准

  • Subjects with infection which fluticasone is not effective
  • Subjects with deep mycosis
  • Subjects with hypersensitivity to fluticason

研究组 & 干预措施

Subjects prescribed ALLERMIST

Subjects with allergic rhinitis prescribed ALLERMIST during study period

干预措施: Fluticasone (Drug)

结局指标

主要结局

The number of adverse events in Japanese subjects with allergic rhinitis treated with fluticasone nasal spray

时间窗: Four weeks

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

相似试验